OC
BIAFW icon

Oarsman Capital’s bioAffinity Technologies BIAFW Stock Holding History

Oarsman Capital’s Portfolio BIAFW Stock Details BIAFW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,448
Closed -$733 – 307
2024
Q4 		$733 Buy
+2,448
New +$2.06K ﹤0.01% 883

Other funds holding BIAFW

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Oarsman Capital's BIAFW Position: Q1 2025 in Review

Oarsman Capital sold out of bioAffinity Technologies (BIAFW) in Q1 2025, closing a stake of 2,448 shares — an estimated $733 sold.

Oarsman Capital first reported a position in BIAFW in Q4 2024 and held it in 1 quarter. The position peaked at $733 in Q4 2024. 4 funds tracked by Wall St. Rank hold BIAFW as of Q1 2025.

  • Oarsman Capital reported no remaining bioAffinity Technologies position as of Q1 2025 after selling out during the quarter.
  • Oarsman Capital sold 2,448 bioAffinity Technologies shares in Q1 2025, an estimated $733.
  • Oarsman Capital first reported a position in bioAffinity Technologies in Q4 2024 and held it in 1 quarter.
  • Oarsman Capital's bioAffinity Technologies position peaked at $733 in Q4 2024.
  • 4 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q1 2025.

Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.